Related Experiment Video
Updated: Jul 18, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumomediastinum as a postinfectious complication of COVID-19 in paediatric patient
Colton Reed Wouters1, Logan Thomas2, Grant Thimesch2
1A T Still University of Health Sciences, Kirksville, Missouri, USA sa202825@atsu.edu.
Abstract:
An adolescent boy presented to the clinic with upper chest pain, anterior neck pain and difficulty swallowing 3 weeks following a COVID-19 infection. The pain started a few days before while participating in football practice. He reported no significant trauma or specific incidence when the pain began. His vital signs were stable and within normal limits. There was tenderness to palpation in the upper sternal area and low anterior neck. A chest X-ray was performed and was originally read by the primary care physician as unremarkable. This was followed by the official radiology read, which identified a spontaneous pneumomediastinum. A follow-up CT was confirmatory. The physician recommended rest and minimal activity, and the symptoms gradually resolved in 1 week. A follow-up 1 week after the initial visit revealed complete resolution by radiograph. One week later, a final set of radiographs confirmed sustained resolution of free air in the mediastinum. He was able to gradually return to normal activity.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Cycle: Exhalation
Pneumothorax-II
Clinical Manifestations:

